We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Dampens Neuronetics' Hopes For Approval of Depression Device
FDA Panel Dampens Neuronetics' Hopes For Approval of Depression Device
February 2, 2007
An FDA advisory panel was unable to give its vote of confidence to a new device meant to treat severe depression last month. This leaves Cyberonics’ vagus nerve stimulation (VNS) therapy to dominate the U.S. market for emerging alternative treatments to currently accepted electroconvulsive therapy (ECT), an analyst says